FreeStyle Libre 3 Continuous Glucose Monitoring System

NCT05962710 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 7

Last updated 2023-07-27

No results posted yet for this study

Summary

The purpose of this study is to characterize the FreeStyle Libre 3 Continuous Glucose Monitoring System performance with respect to YSI reference venous plasma sample measurements.

Conditions

Interventions

DEVICE

FreeStyle Libre 3

FreeStyle Libre 3 Continuous Glucose Monitoring System

Sponsors & Collaborators

  • Abbott Diabetes Care

    lead INDUSTRY

Principal Investigators

  • Shridhara A Karinka, PhD · Abbott Diabetes Care

Eligibility

Min Age
2 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-27
Primary Completion
2023-01-31
Completion
2023-01-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05962710 on ClinicalTrials.gov